Here's some of what is coming soon to NeurologyLive® this week.
|Slideshows|August 4, 2017
Neurology in the News: Migraine, Childhood Epilepsy, and More
Author(s)Natalie Timoshin
New studies shed light on topics such as nonencephalic pain and headache chronicity; benign childhood epilepsy with centrotemporal spikes and social cognition; and causal triggers of Alzheimer disease onset.
Advertisement
Advertisement
Related to this article
Here's some of what is coming soon to NeurologyLive® this week.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 2, 2026.
EpilepsyGTx and Viralgen have entered a manufacturing collaboration to support development of EPY201, an investigational AAV9-based gene therapy for focal refractory epilepsy planned to enter first-in-human testing in 2027.
The FDA extended its review of relutrigine for SCN2A- and SCN8A-related epilepsies by three months, pushing the PDUFA date to December 27, 2026.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 25, 2026.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Accepts Fenebrutinib NDA Under Priority Review for Relapsing and Primary Progressive MS
2
Phase 3 PROPEL Trial to Test Imeroprubart in Generalized Myasthenia Gravis
3
Nipocalimab’s Safety Profile Slightly Favored Over Other Myasthenia Gravis Therapies, Indirect Comparison Shows
4
2026 Rachel Horne Prize Winner Sandra Vukusic, MD, PhD, on Advancing Women's Health in MS
5